Search clinical trials for: Exenatide

Total 358 results

Beijing Dongfang Biotech Co., Ltd.

Not yet recruiting

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Type2 Diabetes Mellitus

China
The Affiliated Hospital of Xuzhou Medical University

Recruiting

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

Type 2 Diabetes Mellitus | Susceptibility, Genetic

China
Christopher D. Verrico

Not yet recruiting

Exenatide For Reducing the Reinforcing Effects of Cocaine

Cocaine Use Disorder

United States
Beijing Dongfang Biotech Co., Ltd.

Not yet recruiting

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients

Type 2 Diabetes Mellitus

China
Vivani Medical, Inc
Medpace, Inc.

Not yet recruiting

Assessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes (LIBERATE-1)

Type 2 Diabetes
AstraZeneca

Not yet recruiting

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED)

Pancreatic Cancer
Azienda Ospedaliero-Universitaria di Parma
University of Parma

Recruiting

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

Hyperinsulinism | Pre Diabetes | type1diabetes | Type2diabetes

Italy
Radboud University Medical Center

Recruiting

BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation (BetaFIT)

Type 1 Diabetes

Netherlands
The University of Texas Health Science Center,...

Recruiting

Exenatide for Smoking Cessation and Prevention of Weight Gain

Smoking Cessation | Weight Gain

United States
Maisa N. Feghali, MD

Recruiting

Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Gestational Diabetes

United States
Radboud University Medical Center

Recruiting

Exendin PET/CT for Imaging of Paragangliomas (ENTRAP)

Paraganglioma

Netherlands
Chinese University of Hong Kong

Recruiting

GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) (GAPP-SVD)

Cerebral Small Vessel Disease

Hong Kong
PegBio Co., Ltd.

Not yet recruiting

Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function

Type2Diabetes

China
Kaiser Permanente
Patient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaborators

Recruiting

Comparison of Type 2 Diabetes Pharmacotherapy Regimens (ON TARGET DM)

Cardiovascular Diseases | Type 2 Diabetes Mellitus

United States
First Affiliated Hospital of Fujian Medical University

Recruiting

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

Insulinoma

China
University Hospital, Basel, Switzerland
Gottfried und Julia Bangerter-Rhyner-Stiftung

Recruiting

Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia (FAST)

Endogenous Hyperinsulinism

Switzerland
Fundació Institut de Recerca de l'Hospital de la...
Instituto de Salud Carlos III

Recruiting

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

Pituitary Diseases | Hypothalamic Diseases | Hypopituitarism | Social Isolation | Panhypopituitarism | Psychological Disorder | Central Diabetes Insipidus | Oxytocin Deficiency

Spain
Radboud University Medical Center
Assistance Publique - Hôpitaux de Paris; Medical University of Vienna; KU Leuven and other collaborators

Recruiting

A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass (Ver-A-image)

Diabetes Mellitus

France, Austria
Seattle Children's Hospital
University of Washington

Recruiting

Brain Activation and Satiety in Children 2 (BASIC2)

Childhood Obesity

United States
Cambridge University Hospitals NHS Foundation Trust
Antaros Medical

Recruiting

Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes (COCONUT)

Obesity | Type 2 Diabetes

United Kingdom
Xiangya Hospital of Central South University

Recruiting

Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

Obesity

China
Radboud University Medical Center
Rijnstate Hospital

Recruiting

GLP1-imaging Before and After Bariatric Surgery

Diabetes Mellitus, Type 2 | Bariatric Surgery Candidate

Netherlands
Radboud University Medical Center
Rijnstate Hospital

Recruiting

GLP1R-imaging in Hypoglycemia

Hypoglycemia

Netherlands
Christina Kruuse

Recruiting

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke (EGRABIS1)

Ischemic Stroke

Denmark
Camillo Ricordi and Jay Skyler
Diabetes Research Institute Foundation

Not yet recruiting

Diabetes Islet Preservation Immune Treatment (DIPIT)

Autoimmune Diseases | Diabetes Mellitus | Hypoglycemia | Diabetes Mellitus, Type 1

United States
University at Buffalo
AstraZeneca

Terminated

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes (1981)

Kidney Diseases | Type2 Diabetes

United States
Cambridge University Hospitals NHS Foundation Trust

Completed

Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers (COCOA)

Cardiovascular Diseases

United Kingdom
Malaria Consortium

Active, not recruiting

Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan

Malaria

South Sudan
University at Buffalo
AstraZeneca

Completed

An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes

Evaluate Ketogenic Stress

United States
University of California, San Francisco

Completed

Micronutrient Supplementation in Children With ASD

Autism Spectrum Disorder

United States
Harvard School of Public Health (HSPH)
Africa Academy for Public Health; Zanzibar Association of People Living with...

Completed

School-Based Assessment of Micronutrient Interventions in Adolescents (SAMIA) in Zanzibar (SAMIA)

Anemia

Tanzania
Beijing Dongfang Biotech Co., Ltd.

Active, not recruiting

Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects

Diabetes Mellitus, Type 2 | Overweight

China
The University of Texas Health Science Center at...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American... and other collaborators

Completed

Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

Diabetes

United States
Radboud University Medical Center

Active, not recruiting

Visualizing Beta Cells in Patients With a History of Gestational Diabetes

Gestational Diabetes

Netherlands
University of Washington
Eli Lilly and Company; Sanofi; Bayer; US Department of Veterans Affairs; University... and other collaborators

Completed

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (FLAT-SUGAR)

Type 2 Diabetes

United States
University College, London

Active, not recruiting

Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease (Exenatide-PD3)

Parkinson's Disease

United Kingdom
Xinqiao Hospital of Chongqing
University of Messina; Azienda Ospedaliera Universitaria Policlinico "G. Martino...

Completed

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Obesity | Overweight | Polycystic Ovary Syndrome (PCOS)

China
Rigshospitalet, Denmark

Active, not recruiting

GLP-1 and Hyperoxia for Organ Protection in Heart Surgery (GLORIOUS)

Stroke | Coronary Disease | Brain Injury | Aortic Valve Disease | Renal Failure | Shock, Cardiogenic

Denmark
CellTrans Inc.

Active, not recruiting

Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

Type 1 Diabetes Mellitus

United States
University of Colorado, Denver
National Center for Advancing Translational Sciences (NCATS)

Completed

Liver and Fat Regulation in Overweight Adolescent Girls (APPLE)

Obesity | Polycystic Ovarian Syndrome | Hepatic Steatosis

United States
The University of Texas Health Science Center at...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

Diabetes Mellitus, Type 2

United States
The University of Texas Health Science Center at...
AstraZeneca

Completed

Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM

Diabetes Mellitus, Type 2

United States
University of Colorado, Denver
Eli Lilly and Company; Amylin Pharmaceuticals, LLC.

Completed

Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes (Exenatide)

Type 2 Diabetes

United States
Novo Nordisk A/S
Eli Lilly and Company; AstraZeneca; United BioSource, LLC

Enrolling by invitation

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Diabetes Mellitus, Type 2 | Diabetes | Weight Management | Medullary Thyroid Carcinoma

United States
Baylor Research Institute

Completed

Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome

Type 2 Diabetes Mellitus | Chronic Kidney Disease | Left Ventricular Diastolic Dysfunction

United States
University of Chicago

Completed

Impact of Exenatide on Sleep Duration

Type 2 Diabetes

United States
Karolinska Institutet

Completed

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects (Rebuild)

Diabetes | Atherosclerosis | Restenosis

Sweden
James J. Peters Veterans Affairs Medical Center
Kessler Institute for Rehabilitation

Completed

Once Weekly GLP-1 in Persons With Spinal Cord Injury

Obesity | Insulin Resistance | Spinal Cord Injuries | Pre Diabetes

United States
University of Maryland, Baltimore

Terminated

Pharmacogenomics of GLP1 Receptor Agonists

Type 2 Diabetes

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration

Cocaine Dependence

United States

Search clinical trials for: Exenatide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations